TABLE 3

Affinities of different DHPs for recombinant Cav1.3 and Cav1.2 channels

Ligand concentration was 0.13 to 0.15 nM. Membrane protein concentration was 40 to 100 μg/ml. Data are given as means ± S.D. for n = 5. Statistical significance of selectivity was obtained as described in Table 2. Selectivity ratios (WT:MUT) were calculated from individual experiments carried out in parallel for both channel isoforms.


Dihydropyridine

Cav1.2

Cav1.3

IC50 WT:MUT
(±)-Isradipine
    IC50 (nM) 0.40 ± 0.21 0.51 ± 0.20 0.76 ± 0.18*
    Slope factor 0.80 ± 0.04 0.96 ± 0.12
Azidopine
    IC50 (nM) 0.46 ± 0.10 0.65 ± 0.11+ 0.74 ± 0.23
    Slope factor 0.85 ± 0.06 1.00 ± 0.11
Nitrendipine
    IC50 (nM) 1.08 ± 0.27 3.59 ± 0.66+++ 0.31 ± 0.11***
    Slope factor 0.82 ± 0.10 0.96 ± 0.12
Nifedipine
    IC50 (nM) 4.45 ± 1.21 20.1 ± 4.78+++ 0.22 ± 0.04***
    Slope factor 0.84 ± 0.12 0.92 ± 0.10
(−)-Isradipine
    IC50 (nM) 29.7 ± 5.56 27.2 ± 3.67 1.09 ± 0.11
    Slope factor 0.88 ± 0.13 0.86 ± 0.12
Amlodipine
    IC50 (nM) 28.4 ± 11.8 60.1 ± 28.3 0.48 ± 0.11***
    Slope factor
0.87 ± 0.11
0.94 ± 0.09

  • + P < 0.05.

  • +++ P < 0.001.

  • * P < 0.05.

  • *** P < 0.001.